EGFR-TKI plus bevacizumab versus EGFR-TKI monotherapy for patients with EGFR mutation-positive advanced non-small cell lung cancer-A propensity score matching analysis
- Resource Type
- Article
- Source
- In
Journal of the Formosan Medical Association September 2021 120(9):1729-1739 - Subject
- Language
- ISSN
- 0929-6646